Allspring Global Investments
TXG icon

Allspring Global Investments’s 10x Genomics TXG Stock Holding History

Allspring Global Investments’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-26,244
Closed -$228K – 1802
2025
Q1 		$228K Sell
26,244
-2,994
-10% -$37.7K ﹤0.01% 1639
2024
Q4 		$415K Sell
29,238
-9,725
-25% -$153K ﹤0.01% 1501
2024
Q3 		$880K Buy
38,963
+37,326
+2,280% +$772K ﹤0.01% 1358
2024
Q2 		$31.8K Buy
1,637
+939
+135% +$24.6K ﹤0.01% 2028
2024
Q1 		$26.2K Buy
698
+371
+113% +$16.3K ﹤0.01% 2050
2023
Q4 		$18.3K Sell
327
-3,202
-91% -$139K ﹤0.01% 1975
2023
Q3 		$146K Buy
+3,529
New +$184K ﹤0.01% 1851
2022
Q2 		– Sell
-724,149
Closed -$55.1M – 2935
2022
Q1 		$55.1M Sell
724,149
-25,419
-3% -$2.22M 0.07% 347
2021
Q4 		$112M Buy
+749,568
New +$115M 0.12% 216

Other funds holding TXG

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Allspring Global Investments's TXG Position: Q2 2025 in Review

Allspring Global Investments sold out of 10x Genomics (TXG) in Q2 2025, closing a stake of 26,244 shares — an estimated $228K sold.

Allspring Global Investments first reported a position in TXG in Q4 2021 and held it in 9 quarters. The position peaked at $112M in Q4 2021. 297 funds tracked by Wall St. Rank hold TXG as of Q2 2025.

  • Allspring Global Investments reported no remaining 10x Genomics position as of Q2 2025 after selling out during the quarter.
  • Allspring Global Investments sold 26,244 10x Genomics shares in Q2 2025, an estimated $228K.
  • Allspring Global Investments first reported a position in 10x Genomics in Q4 2021 and held it in 9 quarters.
  • Allspring Global Investments's 10x Genomics position peaked at $112M in Q4 2021.
  • 297 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2025.

Based on Allspring Global Investments's 13F filing for Q2 2025, filed 25 Jul 2025.